State Street’s BioNTech BNTX Stock Holding History

State Street’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$15.4M	Sell	156,827 -6,710	-4%	-$651K	﹤0.01%	2483
2026 Q2	$15.2M	Sell	163,537 -17,095	-9%	-$1.61M	﹤0.01%	2532
2026 Q1	$16.1M	Buy	180,632 +30,255	+20%	+$3.11M	﹤0.01%	2354
2025 Q4	$14.3M	Buy	150,377 +23,742	+19%	+$2.39M	﹤0.01%	2436
2025 Q3	$12.5M	Sell	126,635 -18,674	-13%	-$2M	﹤0.01%	2513
2025 Q2	$15.5M	Sell	145,309 -7,602	-5%	-$768K	﹤0.01%	2328
2025 Q1	$13.9M	Buy	152,911 +5,367	+4%	+$601K	﹤0.01%	2324
2024 Q4	$16.8M	Sell	147,544 -8,323	-5%	-$950K	﹤0.01%	2311
2024 Q3	$18.5M	Buy	155,867 +3,014	+2%	+$277K	﹤0.01%	2254
2024 Q2	$12.3M	Buy	152,853 +11,404	+8%	+$1.04M	﹤0.01%	2437
2024 Q1	$13M	Buy	141,449 +9,246	+7%	+$887K	﹤0.01%	2422
2023 Q4	$14M	Buy	132,203 +3,780	+3%	+$381K	﹤0.01%	2404
2023 Q3	$14M	Buy	128,423 +2,370	+2%	+$262K	﹤0.01%	2399
2023 Q2	$13.6M	Buy	126,053 +1,394	+1%	+$157K	﹤0.01%	2472
2023 Q1	$15.5M	Buy	124,659 +4,806	+4%	+$660K	﹤0.01%	2389
2022 Q4	$18M	Buy	119,853 +13,268	+12%	+$2.04M	﹤0.01%	2317
2022 Q3	$14.4M	Buy	106,585 +2,662	+3%	+$407K	﹤0.01%	2479
2022 Q2	$15.5M	Sell	103,923 -8,313	-7%	-$1.27M	﹤0.01%	2429
2022 Q1	$19.1M	Buy	112,236 +55,162	+97%	+$9.27M	﹤0.01%	2447
2021 Q4	$14.7M	Buy	57,074 +5,517	+11%	+$1.51M	﹤0.01%	2679
2021 Q3	$14.1M	Buy	51,557 +42,747	+485%	+$13.6M	﹤0.01%	2687
2021 Q2	$1.97M	Buy	8,810 +1,031	+13%	+$194K	﹤0.01%	3551
2021 Q1	$849K	Buy	7,779 +179	+2%	+$19K	﹤0.01%	3657
2020 Q4	$620K	Buy	+7,600	New	+$746K	﹤0.01%	3626

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Davern Capital Partners Ny, New York $514M AUM 16.9% 1-Year Est. Return

GSK plc London $497M AUM 35.1% 1-Year Est. Return

State Street's BNTX Position: Q3 2026 in Review

State Street reduced its BioNTech (BNTX) stake by 4.1% in Q3 2026, selling an estimated $651K and leaving 156,827 shares worth $15.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

State Street first reported a position in BNTX in Q4 2020 and has held it in 24 quarters since. The position peaked at $19.1M in Q1 2022. 223 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

State Street held 156,827 shares of BioNTech worth $15.4M as of Q3 2026.
State Street sold 6,710 BioNTech shares in Q3 2026, an estimated $651K.
BioNTech made up ﹤0.01% of State Street's portfolio in Q3 2026, its #2483 holding.
State Street first reported a position in BioNTech in Q4 2020 and has held it in 24 quarters since.
State Street's BioNTech position peaked at $19.1M in Q1 2022.
223 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on State Street's 13F filing for Q3 2026, filed 12 Nov 2026.